focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 673.00
Bid: 675.00
Ask: 676.00
Change: 3.00 (0.45%)
Spread: 1.00 (0.148%)
Open: 673.00
High: 676.50
Low: 668.00
Prev. Close: 670.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tate & Lyle Capital Markets Event

14 Jan 2016 07:00

14 January 2016 – Tate & Lyle PLC

Tate & Lyle Capital Markets Event

Tate & Lyle PLC (‘Tate & Lyle’) is today hosting a Capital Markets event for investors and analysts.

The event will focus on the Group’s Speciality Food Ingredients division and Innovation and Commercial Development organisation and will be hosted by Javed Ahmed, Chief Executive, Nick Hampton, Chief Financial Officer alongside other members of the Tate & Lyle senior management team.

No new material trading information or update will be provided during the event.

The audiocast of the presentation and accompanying slides will be available from the investor relations section of the company’s website (http://www.tateandlyle.com/investorrelations/Pages/InvestorRelations.aspx) shortly after the event.

END

For more information contact Tate & Lyle PLC:

Christopher Marsh, VP, Investor and Media Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 203 727 1323 or Mobile: +44 (0) 7775 641 807

About Tate & Lyle:

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, with operations in over 30 locations worldwide.

Tate & Lyle operates through two global divisions, Speciality Food Ingredients and Bulk Ingredients, supported by our Innovation and Commercial Development and Global Operations groups. The Group's strategy is to become a leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving Bulk Ingredients for sustained cash generation to fuel this growth.

Speciality Food Ingredients consists of three platforms: Texturants, which includes speciality starches and stabilisers; Sweeteners, which comprises nutritive sweeteners and our range of no-calorie sweeteners including SPLENDA® Sucralose; and our Health and Wellness portfolio which includes speciality fibres and our salt-reduction offering. Additionally, our Food Systems business provides a wide variety of blended ingredient solutions.

Tate & Lyle Bulk Ingredients includes bulk sweeteners, industrial starches and fermentation products (primarily acidulants). Corn co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2015, Tate & Lyle sales totalled £2.7 billion. For more information, please visit http://www.tateandlyle.com. SPLENDA® is a trademark of Heartland Consumer Products LLC.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160113005953/en/

Copyright Business Wire 2016

Date   Source Headline
31st May 20124:43 pmBUSHolding(s) in Company
31st May 20127:00 amBUSFinal Results
21st May 20124:47 pmBUSHolding(s) in Company
11th May 20124:39 pmBUSTransaction in Own Shares
9th May 20124:46 pmBUSTransaction in Own Shares
1st May 201212:11 pmBUSTotal Voting Rights
20th Apr 20127:00 amBUSDisposal
19th Apr 201212:57 pmBUSAdditional Listing
16th Apr 201211:07 amBUSHolding(s) in Company
13th Apr 201212:15 pmBUSHolding(s) in Company
5th Apr 20125:45 pmBUSTransaction in Own Shares
5th Apr 201211:47 amBUSHolding(s) in Company
2nd Apr 20125:13 pmBUSTransaction in Own Shares
2nd Apr 201210:57 amBUSTotal Voting Rights
30th Mar 20124:42 pmBUSHolding(s) in Company
30th Mar 20127:00 amBUSTrading Statement
27th Mar 20126:13 pmBUSHolding(s) in Company
13th Mar 20129:57 amBUSDirector/PDMR Shareholding
8th Mar 20125:36 pmBUSTransaction in Own Shares
7th Mar 20125:07 pmBUSTransaction in Own Shares
6th Mar 20125:04 pmBUSTransaction in Own Shares
5th Mar 20125:07 pmBUSTransaction in Own Shares
1st Mar 20125:14 pmBUSTransaction in Own Shares
1st Mar 20129:23 amBUSTotal Voting Rights
22nd Feb 20129:20 amBUSDirectorate Change
20th Feb 20125:03 pmBUSTransaction in Own Shares
16th Feb 20123:34 pmBUSDirector/PDMR Shareholding
15th Feb 20125:05 pmBUSTransaction in Own Shares
10th Feb 201210:20 amBUSDirector Declaration
9th Feb 20127:00 amBUSInterim Management Statement
6th Feb 20124:50 pmBUSHolding(s) in Company
1st Feb 201210:17 amBUSTotal Voting Rights
30th Jan 20121:46 pmBUSHolding(s) in Company
10th Jan 20123:27 pmBUSDirector/PDMR Shareholding
9th Jan 20124:12 pmBUSTransaction in Own Shares
3rd Jan 20124:25 pmBUSBlocklisting Interim Review
3rd Jan 201210:45 amBUSTotal Voting Rights
20th Dec 201111:01 amBUSHolding(s) in Company
14th Dec 20114:59 pmBUSTransaction in Own Shares
14th Dec 20113:13 pmBUSHolding(s) in Company
13th Dec 20115:28 pmBUSTransaction in Own Shares
12th Dec 20115:34 pmBUSTransaction in Own Shares
9th Dec 20115:49 pmBUSTransaction in Own Shares
8th Dec 20116:09 pmBUSTransaction in Own Shares
7th Dec 20117:10 amBUSTransaction in Own Shares
5th Dec 20112:35 pmBUSHolding(s) in Company
2nd Dec 20114:48 pmBUSTransaction in Own Shares
1st Dec 20116:19 pmBUSTransaction in Own Shares
1st Dec 20114:37 pmBUSHolding(s) in Company
1st Dec 20119:57 amBUSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.